If youre transitioning off a compounded dose , that supervision is especially importantyour provider will look at your prior dose, how long youve used it, and your response to decide whether you continue at a comparable dose or restart the standard step-up schedule to keep side effects manageable
Lilly's recently released research data indicates that all doses of Retatrutide significantly reduced liver fat content at week 48 compared to the placebo group
Its important to consider that the dose and individual patient characteristics can influence the timing of semaglutide GLP-1s effects
Provider may start low and adjust as tolerated
TRIUMPH-4 was the first to report positive results in December 2025
Commonly reported effects for both peptides include injection-site reactions (redness, itching, swelling), transient flushing, headache, lightheadedness, and water retention